Literature DB >> 22687951

Topical hindpaw application of L-menthol decreases responsiveness to heat with biphasic effects on cold sensitivity of rat lumbar dorsal horn neurons.

A H Klein1, C M Sawyer, K Takechi, A Davoodi, M A Ivanov, M I Carstens, E Carstens.   

Abstract

Menthol is used in pharmaceutical applications because of its desired cooling and analgesic properties. The neural mechanism by which topical application of menthol decreases heat pain is not fully understood. We investigated the effects of topical menthol application on lumbar dorsal horn wide dynamic range and nociceptive-specific neuronal responses to noxious heat and cooling of glabrous hindpaw cutaneous receptive fields. Menthol increased thresholds for responses to noxious heat in a concentration-dependent manner. Menthol had a biphasic effect on cold-evoked responses, reducing the threshold (to warmer temperatures) at a low (1%) concentration and increasing threshold and reducing response magnitude at high (10%, 40%) concentrations. Menthol had little effect on responses to innocuous or noxious mechanical stimuli, ruling out a local anesthetic action. Application of 40% menthol to the contralateral hindpaw tended to reduce responses to cooling and noxious heat, suggesting a weak heterosegmental inhibitory effect. These results indicate that menthol has an analgesic effect on heat sensitivity of nociceptive dorsal horn neurons, as well as biphasic effects on cold sensitivity, consistent with previous behavioral observations.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687951      PMCID: PMC3402706          DOI: 10.1016/j.neuroscience.2012.05.061

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  57 in total

1.  Peripheral GABA(A) receptors: evidence for peripheral primary afferent depolarization.

Authors:  S M Carlton; S Zhou; R E Coggeshall
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Ca2+-dependent PKC activation mediates menthol-induced desensitization of transient receptor potential M8.

Authors:  Junji Abe; Hiroshi Hosokawa; Yosuke Sawada; Kiyoshi Matsumura; Shigeo Kobayashi
Journal:  Neurosci Lett       Date:  2005-12-27       Impact factor: 3.046

3.  Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate.

Authors:  Beiying Liu; Feng Qin
Journal:  J Neurosci       Date:  2005-02-16       Impact factor: 6.167

4.  Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation.

Authors:  Louis S Premkumar; Manish Raisinghani; Sandeep C Pingle; Cheng Long; Fátima Pimentel
Journal:  J Neurosci       Date:  2005-12-07       Impact factor: 6.167

5.  TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol.

Authors:  Barbara Namer; Frank Seifert; Hermann Otto Handwerker; Christian Maihöfner
Journal:  Neuroreport       Date:  2005-06-21       Impact factor: 1.837

6.  Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids.

Authors:  Adam C Hall; Carolyn M Turcotte; Brooke A Betts; Wing-Yee Yeung; Abena S Agyeman; Lâle A Burk
Journal:  Eur J Pharmacol       Date:  2004-12-03       Impact factor: 4.432

7.  PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain.

Authors:  Tibor Rohács; Coeli M B Lopes; Ioannis Michailidis; Diomedes E Logothetis
Journal:  Nat Neurosci       Date:  2005-04-24       Impact factor: 24.884

8.  Selectivity of lingual nerve fibers to chemical stimuli.

Authors:  Y Wang; R P Erickson; S A Simon
Journal:  J Gen Physiol       Date:  1993-06       Impact factor: 4.086

9.  Psychophysical study of the effects of topical application of menthol in healthy volunteers.

Authors:  Samar Hatem; Nadine Attal; Jean-Claude Willer; Didier Bouhassira
Journal:  Pain       Date:  2006-03-09       Impact factor: 6.961

10.  Tongue adaptation temperature influences lingual nerve responses to thermal and menthol stimulation.

Authors:  R F Lundy; R J Contreras
Journal:  Brain Res       Date:  1995-04-03       Impact factor: 3.252

View more
  7 in total

Review 1.  TRPM8 and Migraine.

Authors:  Greg Dussor; Yu-Qing Cao
Journal:  Headache       Date:  2016-09-16       Impact factor: 5.887

2.  Thermosensitive transient receptor potential (TRP) channel agonists and their role in mechanical, thermal and nociceptive sensations as assessed using animal models.

Authors:  A H Klein; Minh Trannyguen; Christopher L Joe; Carstens M Iodi; E Carstens
Journal:  Chemosens Percept       Date:  2015-08       Impact factor: 1.833

3.  Dry eye modifies the thermal and menthol responses in rat corneal primary afferent cool cells.

Authors:  Masayuki Kurose; Ian D Meng
Journal:  J Neurophysiol       Date:  2013-05-01       Impact factor: 2.714

4.  Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.

Authors:  Yixuan Wang; Sisi Cao; Kaiyue Yu; Fengdie Yang; Xiuming Yu; Yuanhao Zhai; Chuanbin Wu; Yuehong Xu
Journal:  Int J Nanomedicine       Date:  2019-07-30

Review 5.  Genes, molecules and patients--emerging topics to guide clinical pain research.

Authors:  Shafaq Sikandar; Ryan Patel; Sital Patel; Sanam Sikander; David L H Bennett; Anthony H Dickenson
Journal:  Eur J Pharmacol       Date:  2013-03-13       Impact factor: 4.432

6.  Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: a comparison with topical menthol.

Authors:  Ryan Patel; Leonor Gonçalves; Mathew Leveridge; Stephen R Mack; Alan Hendrick; Nicola L Brice; Anthony H Dickenson
Journal:  Pain       Date:  2014-07-30       Impact factor: 6.961

Review 7.  Cellular and Molecular Targets of Menthol Actions.

Authors:  Murat Oz; Eslam G El Nebrisi; Keun-Hang S Yang; Frank C Howarth; Lina T Al Kury
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.